Respiratory Infections News

Children who have multiple long-term conditions are as almost three times more likely to die after COVID-19 compared with children who do not, according to data published in Journal of the Royal Society of Medicine.

Most children who did not receive antibiotics for pneumonia did not experience treatment failure or severe outcomes, according to study findings published in JAMA Network Open.

Data from a phase 3 trial designed to compare pralsetinib with standard therapy for certain patients with advanced lung cancer revealed a risk for severe — and potentially fatal — infections with the drug, according to its manufacturer.

A CDC advisory committee on Wednesday recommended that adults aged 65 years or older and anyone who is at least moderately immunocompromised receive a second dose of COVID-19 vaccine this season.

Another monoclonal antibody for preventing respiratory syncytial virus disease in infants could enter the market as early as next year, based on the results of two studies presented at IDWeek, Merck said.

Fewer patients with bronchiectasis vs. COPD had at least one cardiovascular comorbidity/risk factor, according to results published in Respiratory Medicine.

BOSTON — In a sample of 114 adults with bronchiectasis, 46.5% received a score that indicated impaired swallow function, according to a presentation at the CHEST Annual Meeting.

Children with health care-associated respiratory syncytial virus were more likely to need respiratory support, compared with children with community-associated RSV, according to a recent study.

BOSTON — BACES score in Mycobacterium avium complex lung disease is linked to clinical treatment outcomes and may be able to predict clinical improvement, according to data presented at the CHEST Annual Meeting.